CD22 & CD79B
Loading...Anti-CD22 & CD79B Products
+ Filter
Loading...-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
- Anti-Human CD22 Recombinant Antibody (RFB4) (TAB-1728CL)
-
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody (TAB-1722CL) (TAB-1722CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1717CL) (TAB-1717CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1718CL) (TAB-1718CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1719CL) (TAB-1719CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody (TAB-1729CL) (TAB-1729CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: IF, FC
- Human Anti-CD22 Recombinant Antibody (TAB-1724CL) (TAB-1724CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib
- Human Anti-CD22 Recombinant Antibody (TAB-1725CL) (TAB-1725CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: Block, Cyt, ELISA, FuncS
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
- Human Anti-CD22 Recombinant Antibody (HPAB-0195-LSX) (HPAB-0195-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: Apop, Cyt, FC, WB, Inhib, FuncS, IF, ELISA
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
-
- Application: ELISA, In vivo
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1715CL-F(E)) (TAB-1715CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1716CL-F(E)) (TAB-1716CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0196-LSX) (HPAB-0196-LSX)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, IP, RIA
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2-Cys) (TAB-0197CL-S(P))
-
- Application: ELISA, In vivo
- Mouse Anti-CD22 Recombinant Antibody (clone 5LB129) (MOB-0349MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1717CL-F(E)) (TAB-1717CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Human Anti-CD22 Recombinant Antibody (HPAB-0197-LSX) (HPAB-0197-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB, FC, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: IF, FC
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
-
- Application: ELISA, In vivo
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
-
- Application: ELISA, In vivo
-
- Species Reactivity: Human
- Type: Mouse antibody
- Application: ELISA
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1718CL-F(E)) (TAB-1718CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0198-LSX) (HPAB-0198-LSX)
-
- Species Reactivity: Human, Cynomolgus monkey
- Type: Mouse IgG
- Application: ELISA, WB, IF, FC, SPR
- Human Anti-CD22 Recombinant Antibody (TAB-1715CL) (TAB-1715CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody (TAB-1716CL) (TAB-1716CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1719CL-F(E)) (TAB-1719CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
-
- Species Reactivity: M. fascicularis
- Type: Mouse IgG
- Application: ELISA, FuncS
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1720CL-F(E)) (TAB-1720CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
-
- Targets: CD22 & CD79b
- Type: Tandem Diabody
- Application: FC
- Anti-CD79b (SN8)-vc-MMAE ADC (RG7596) (ADC-L029)
-
- Target: CD79b
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b-vc-MMAE ADC (ADC-034LZY)
-
- Target: CD79b
- Linker: VC(Valine-citrulline)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b-MCC-DM1 ADC (ADC-084LZY)
-
- Target: CD79b
- Linker: MCC (4-(Nmaleimidomethyl)cyclohexane-1 carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD79b-mc-MMAF ADC (ADC-085LZY)
-
- Target: CD79b
- Linker: mc(maleimidocaproyl)
- Drug: MMAF(monomethyl auristatin F)
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: IP, WB
- Anti-CD79b (clone SN8)-MCC-DM1 ADC (ADC-202LZY)
-
- Target: CD79b
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD79b (clone SN8)-mc-vc-PABC-MMAE ADC (ADC-203LZY)
-
- Target: CD79b
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b (clone SN8)-mc-MMAF ADC (ADC-204LZY)
-
- Target: CD79b
- Linker: mc(maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-cyCD79b (clone 10D10)-MCC-DM1 ADC (ADC-216LZY)
-
- Target: cyCD79b
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate))
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD79b (clone huMA79b.v18)-MC-MMAF ADC (ADC-048CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone huMA79b.v18)-BMPEO-DM1 ADC (ADC-049CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone huMA79b.v18)-MCvcPAB-MMAE ADC (ADC-050CL)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone huMA79b.v28)-MC-MMAF ADC (ADC-051CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
- Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC (ADC-052CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22-CL2A-SN-38 ADC (ADC-030LCT)
-
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD22-CL2E-SN-38 ADC (ADC-031LCT)
-
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-CD79b (Polatuzumab)-vc-MMAE ADC (ADC-087LCT)
-
- Target: CD79b
- Linker: VC (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
- THIO-Anti-CD79b (Polatuzumab)-MC-VC-PABC-MMAE ADC (ADC-088LCT)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79 (bSN8)-mcc-DM1 ADC (ADC-089LCT)
-
- Target: CD79b
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
- Anti-CD22 (clone 10F4v3)-MCC-DM1 ADC (ADC-194LZY)
-
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD22 (clone 10F4v3)-mc-vc-PABC-MMAE ADC (ADC-195LZY)
-
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD79b (clone SN8)-SPP-DM1 ADC (ADC-201LZY)
-
- Target: CD79b
- Linker: SPP(N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone ch2F2)-SMCC-DM1 ADC (ADC-202CL)
-
- Target: CD79b
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone hu2F2.D7)-SMCC-DM1 ADC (ADC-203CL)
-
- Target: CD79b
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone hu2F2.D7)-BMPEO-DMl ADC (ADC-204CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone hu2F2.D7)-MC-MMAF ADC (ADC-205CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone hu2F2.D7)-MCvcPAB-MMAE ADC (ADC-206CL)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone ch2F2)-MC-MMAF ADC (ADC-207CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone ch2F2)-MC-MMAF ADC (ADC-208CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone ch10D10)-MC-MMAF ADC (ADC-054CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone ch10D10)-BMPEO-DM1 ADC (ADC-055CL)
-
- Target: CD79b
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-CD79b (clone ch10D10)-MC-vc-PAB-MMAE ADC (ADC-056CL)
-
- Target: CD79b
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (clone MA79b)-MC-MMAF ADC (ADC-057CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD79b (clone MA79b)-MC-MMAF ADC (ADC-058CL)
-
- Target: CD79b
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Host Species: Mouse
- Specificity: Human
- Type: Mouse antibody
- Classification: Fab glycosylation
- Glycosylation site: FR1 of VK
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome.
CD79B (CD79b Molecule) is a Protein Coding gene. Diseases associated with CD79B include Agammaglobulinemia 6, Autosomal Recessive and Agammaglobulinemia, Non-Bruton Type. Among its related pathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Innate Immune System. Gene Ontology (GO) annotations related to this gene include transmembrane signaling receptor activity.


BCR Signaling Pathway